Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Doximity Inc Cl A
(NY:
DOCS
)
24.33
+0.06 (+0.25%)
Streaming Delayed Price
Updated: 12:48 PM EDT, Apr 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Doximity Inc Cl A
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
NYSE:DOCS—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
April 12, 2024
Via
Chartmill
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Doximity, Inc. (DOCS) on Behalf of Investors
April 05, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Doximity, Inc. (DOCS) on Behalf of Investors
April 05, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Doximity, Inc. (DOCS) on Behalf of Investors
April 03, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
6 Analysts Assess Doximity: What You Need To Know
April 02, 2024
Via
Benzinga
NYSE:DOCS, a growth stock which is not overvalued.
March 22, 2024
Investors should take note ofDOXIMITY INC-CLASS A (NYSE:DOCS), a growth stock that remains attractively priced.
Via
Chartmill
DOXIMITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Doximity, Inc. on Behalf of Doximity Stockholders and Encourages Investors to Contact the Firm
April 02, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Inquire About Securities Class Action Investigation – DOCS
April 01, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
What 6 Analyst Ratings Have To Say About Doximity
March 15, 2024
Via
Benzinga
NYSE:DOCS—A High-Growth Stock Gearing Up for Its Next Upward Move.
March 12, 2024
Why DOXIMITY INC-CLASS A (NYSE:DOCS) Is a Promising High-Growth Stock in the Midst of Consolidation.
Via
Chartmill
NYSE:DOCS stands out as a growth opportunity that won't break the bank.
February 29, 2024
Investors seeking growth at a reasonable cost should explore NYSE:DOCS.
Via
Chartmill
Forecasting The Future: 5 Analyst Projections For Doximity
February 26, 2024
Via
Benzinga
Is NYSE:DOCS on the Verge of a Major Breakout as a Strong Growth Stock?
February 19, 2024
DOXIMITY INC-CLASS A (NYSE:DOCS)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
Via
Chartmill
HIMS Stock Breaks Out On Powerful Turnaround Quarter
February 27, 2024
"In 2024, we expect to eclipse $1 billion in revenue and deliver our first full year of net income profitability.": CEO Andrew Dudum
Via
Investor's Business Daily
Doximity to Participate in Upcoming Investor Events
February 22, 2024
From
Doximity
Via
Business Wire
2 Beaten-Down Stocks to Buy and Hold for 10 Years
February 21, 2024
One is a longtime healthcare leader, the other a newcomer; both have bright futures despite recent obstacles.
Via
The Motley Fool
1 Cash-Gushing Stock Down 70% to Buy and Hold Forever
February 21, 2024
This healthcare upstart, with a free-cash-flow margin of 27% even after removing stock-based compensation, deserves a long look from investors.
Via
The Motley Fool
What's Going With Medical Professionals-Networking Service Doximity Stock Today?
February 09, 2024
Doximity exceeds Q3 2024 expectations with $135.3 million revenue, up 17% YoY. CEO Jeff Tangney highlights double-digit growth, beating adjusted EPS and raising FY2024 outlook.
Via
Benzinga
Recap: Doximity Q3 Earnings
February 08, 2024
Via
Benzinga
Earnings Scheduled For February 8, 2024
February 08, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.
Via
Benzinga
In the world of growth stocks, NYSE:DOCS shines as a value proposition.
February 07, 2024
Investors seeking growth at a reasonable cost should explore DOXIMITY INC-CLASS A (NYSE:DOCS).
Via
Chartmill
The Top Healthcare Stocks to Buy With $100
December 21, 2023
These stocks haven't been popular with investors lately.
Via
The Motley Fool
Doximity Ranked #1 Best in KLAS Telehealth Video Conferencing Platform for Third Consecutive Year
February 08, 2024
From
Doximity
Via
Business Wire
Doximity Announces Fiscal 2024 Third Quarter Financial Results
February 08, 2024
From
Doximity
Via
Business Wire
Doximity to Release Fiscal 2024 Third Quarter Results on February 8, 2024
January 18, 2024
From
Doximity
Via
Business Wire
For those who appreciate growth without the sticker shock, NYSE:DOCS is worth considering.
January 16, 2024
Don't overlook DOXIMITY INC-CLASS A (NYSE:DOCS)—a stock with solid growth prospects and a reasonable valuation.
Via
Chartmill
3 Stocks to Capitalize on the Telehealth Explosion
January 08, 2024
These three telehealth stocks are leading the way for improved telehealth offerings, highlighted after the pandemic.
Via
InvestorPlace
7 Stocks that Multiple AI Bots Predict Will Soar in the Near Future
December 29, 2023
AI chatbots including ChatGPT and Bard believe these stocks are headed higher in the future, perhaps the near future.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Investors should take note of NYSE:DOCS, a growth stock that remains attractively priced.
December 26, 2023
DOXIMITY INC-CLASS A (NYSE:DOCS), a growth stock which is not overvalued.
Via
Chartmill
10 Health Care Stocks With Whale Alerts In Today's Session
December 25, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.